Intec Pharma Ltd
Intec Pharma Ltd., a pioneering biopharmaceutical company headquartered in Israel, focuses on developing innovative therapies for patients with unmet medical needs. Founded in 2005, Intec Pharma has made significant strides in the pharmaceutical industry, particularly in the areas of drug delivery systems and therapeutic solutions for chronic conditions. The company is renowned for its proprietary Accordion Pill® technology, which enhances the bioavailability and efficacy of oral medications. This unique approach positions Intec Pharma as a leader in the development of advanced drug formulations, particularly for gastrointestinal disorders and central nervous system diseases. With a commitment to improving patient outcomes, Intec Pharma has established a strong market presence, underscored by its ongoing clinical trials and collaborations with key industry partners. The company continues to drive innovation, aiming to transform the landscape of drug delivery and therapeutic efficacy.
DitchCarbon Score
How does Intec Pharma Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Intec Pharma Ltd's score of 29 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Intec Pharma Ltd, headquartered in Israel (IL), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is identified as a merged entity, inheriting performance data from Indaptus Therapeutics, Inc. However, there are no documented reduction targets or climate pledges available for Intec Pharma Ltd at this time. As a part of the broader industry context, companies in the pharmaceutical sector are increasingly focusing on sustainability and climate commitments. While Intec Pharma Ltd has not disclosed specific initiatives or targets, the industry trend leans towards adopting science-based targets and engaging in climate-related disclosures to enhance transparency and accountability. In summary, Intec Pharma Ltd has not provided emissions data or specific climate commitments, reflecting a need for further engagement in sustainability practices within the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 1,879,000 | 0,000,000 | 00,000 |
| Scope 2 | - | - | 00,000 |
| Scope 3 | - | - | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Intec Pharma Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
